Chest Pain, Statins, Troponin Elevation, and Myopathy: A Diagnostic and Management Dilemma

Published:November 08, 2020DOI:
      A 64-year-old man with known ischemic heart disease and previous myocardial infarction and stent implantation presented to the Emergency Department with bilateral arm pain and chest discomfort with mixed features. He described a dull, central sensation within the chest, which did not radiate to the neck, jaw, or back. Additionally, he had a 3-week history of fatigue and intermittent myalgias, predominantly affecting the shoulders on exertion. Cardiac risk factors included hypertension and hypercholesterolemia. There was no history of diabetes mellitus, with normal baseline renal function (creatinine 80 µmol/L, estimated glomerular filtration rate >90 mL/min/1.73 m2). Regular medications included atorvastatin, olmesartan, hydrochlorothiazide, spironolactone, and allopurinol. He was known to have mild left ventricular dysfunction with a previous transthoracic echocardiogram showing an ejection fraction of 45%. The patient has been on long-term statin therapy, but 3 weeks prior to presentation, atorvastatin 40 mg had been changed to rosuvastatin 20 mg and symptoms had begun at that time.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Schmid J
        • Liesinger L
        • Birner-Gruenberger R
        • et al.
        Elevated cardiac troponin T in patients with skeletal myopathies.
        J Am Coll Cardiol. 2018; 71: 1540-1549
        • Jaffe AS
        • Vasile VC
        • Milone M
        • Saenger AK
        • Olson KN
        • Apple FS
        Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T.
        J Am Coll Cardiol. 2011; 58: 1819-1824
        • Dalakas MC
        Inflammatory muscle diseases.
        N Engl J Med. 2015; 373: 393-394
        • Lundberg IE
        The heart in dermatomyositis and polymyositis.
        Rheumatology (Oxford). 2006; 45: iv18-iv21
        • Kassardjian CD
        • Lennon VA
        • Alfugham NB
        • et al.
        Clinical features and treatment outcomes of necrotizing autoimmune myopathy.
        JAMA Neurol. 2015; 72: 996-1003
        • Rai SK
        • Choi HK
        • Sayre EC
        • et al.
        Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study.
        Rheumatology (Oxford). 2016; 55: 461-469
        • Tisseverasinghe A
        • Bernatsky S
        • Pineau CA
        Arterial events in persons with dermatomyositis and polymyositis.
        J Rheumatol. 2009; 36: 1943-1946
        • Lundberg IE
        • Forbess CJ
        Mortality in idiopathic inflammatory myopathies.
        Clin Exp Rheumatol. 2008; 26: S109-S114
        • Cruellas MG
        • Viana Vdos S
        • Levy-Neto M
        • Souza FH
        • Shinjo SK
        Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis.
        Clinics (Sao Paulo). 2013; 68: 909-914
        • Hengstman GJD
        • Vree Egberts WTM
        • Seelig HP
        • et al.
        Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen.
        Ann Rheum Dis. 2006; 65: 242-245
        • Spiro J
        • Butts DO
        Atorvastatin-induced dermatomyositis. Resolution with change in statin?.
        J Clin Rheum. 2018; 24: 406-409